Structure

Physi-Chem Properties

Molecular Weight:  634.34
Volume:  631.428
LogP:  1.855
LogD:  2.261
LogS:  -3.411
# Rotatable Bonds:  7
TPSA:  183.21
# H-Bond Aceptor:  11
# H-Bond Donor:  6
# Rings:  6
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.175
Synthetic Accessibility Score:  5.626
Fsp3:  0.824
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.895
MDCK Permeability:  3.5155888326698914e-05
Pgp-inhibitor:  0.57
Pgp-substrate:  0.855
Human Intestinal Absorption (HIA):  0.942
20% Bioavailability (F20%):  0.073
30% Bioavailability (F30%):  0.853

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.102
Plasma Protein Binding (PPB):  70.0096664428711%
Volume Distribution (VD):  0.499
Pgp-substrate:  7.730370044708252%

ADMET: Metabolism

CYP1A2-inhibitor:  0.006
CYP1A2-substrate:  0.098
CYP2C19-inhibitor:  0.008
CYP2C19-substrate:  0.52
CYP2C9-inhibitor:  0.007
CYP2C9-substrate:  0.043
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.047
CYP3A4-inhibitor:  0.511
CYP3A4-substrate:  0.473

ADMET: Excretion

Clearance (CL):  1.908
Half-life (T1/2):  0.883

ADMET: Toxicity

hERG Blockers:  0.053
Human Hepatotoxicity (H-HT):  0.177
Drug-inuced Liver Injury (DILI):  0.064
AMES Toxicity:  0.308
Rat Oral Acute Toxicity:  0.197
Maximum Recommended Daily Dose:  0.543
Skin Sensitization:  0.165
Carcinogencity:  0.762
Eye Corrosion:  0.003
Eye Irritation:  0.012
Respiratory Toxicity:  0.894

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC318135

Natural Product ID:  NPC318135
Common Name*:   Withalongolide I
IUPAC Name:   (2R)-5-(hydroxymethyl)-2-[(1S)-1-[(3R,8S,9S,10R,13S,14S,17R)-10-(hydroxymethyl)-13-methyl-1-oxo-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl]-4-methyl-2,3-dihydropyran-6-one
Synonyms:   withalongolide I
Standard InCHIKey:  PRNFAKRMKREHJM-XYLPFXPVSA-N
Standard InCHI:  InChI=1S/C34H50O11/c1-16-10-25(44-31(42)21(16)13-35)17(2)22-6-7-23-20-5-4-18-11-19(43-32-30(41)29(40)28(39)26(14-36)45-32)12-27(38)34(18,15-37)24(20)8-9-33(22,23)3/h4,17,19-20,22-26,28-30,32,35-37,39-41H,5-15H2,1-3H3/t17-,19+,20-,22+,23-,24-,25+,26+,28+,29-,30+,32+,33+,34-/m0/s1
SMILES:  CC1=C(C(=O)OC(C1)C(C)C2CCC3C2(CCC4C3CC=C5C4(C(=O)CC(C5)OC6C(C(C(C(O6)CO)O)O)O)CO)C)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1934461
PubChem CID:   56926205
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001125] Steroid lactones
          • [CHEMONTID:0001560] Withanolides and derivatives
            • [CHEMONTID:0001561] Withanolide glycosides and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14874 Physalis longifolia Species Solanaceae Eukaryota n.a. aerial part n.a. PMID[22098611]
NPO14874 Physalis longifolia Species Solanaceae Eukaryota aerial parts n.a. n.a. PMID[22098611]
NPO14874 Physalis longifolia Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT169 Cell Line B16-F10 Mus musculus IC50 > 10000.0 nM PMID[520654]
NPT170 Cell Line SK-MEL-28 Homo sapiens IC50 > 10000.0 nM PMID[520654]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[520654]
NPT27 Others Unspecified IC50 > 10000.0 nM PMID[520654]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC318135 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9417 High Similarity NPC173347
0.9412 High Similarity NPC245094
0.9231 High Similarity NPC129434
0.9224 High Similarity NPC232258
0.918 High Similarity NPC231240
0.9174 High Similarity NPC476966
0.9106 High Similarity NPC316915
0.9091 High Similarity NPC311534
0.9068 High Similarity NPC202051
0.8974 High Similarity NPC291564
0.8966 High Similarity NPC207637
0.8908 High Similarity NPC170084
0.8908 High Similarity NPC476204
0.8852 High Similarity NPC42399
0.8772 High Similarity NPC118225
0.8772 High Similarity NPC246205
0.877 High Similarity NPC47113
0.877 High Similarity NPC174367
0.875 High Similarity NPC475182
0.8739 High Similarity NPC122971
0.872 High Similarity NPC471855
0.8718 High Similarity NPC473882
0.871 High Similarity NPC473593
0.8699 High Similarity NPC329784
0.8699 High Similarity NPC240070
0.8699 High Similarity NPC146456
0.8699 High Similarity NPC117702
0.8699 High Similarity NPC471357
0.8699 High Similarity NPC469757
0.8689 High Similarity NPC177820
0.8689 High Similarity NPC30188
0.8684 High Similarity NPC295389
0.8678 High Similarity NPC269642
0.8678 High Similarity NPC28532
0.8667 High Similarity NPC476150
0.8667 High Similarity NPC129393
0.8667 High Similarity NPC476127
0.8667 High Similarity NPC470312
0.8655 High Similarity NPC473617
0.8655 High Similarity NPC239293
0.8655 High Similarity NPC473828
0.8651 High Similarity NPC146857
0.8651 High Similarity NPC32793
0.8651 High Similarity NPC247190
0.8651 High Similarity NPC116075
0.8651 High Similarity NPC469749
0.8629 High Similarity NPC473620
0.8607 High Similarity NPC469789
0.8607 High Similarity NPC27363
0.8583 High Similarity NPC329636
0.8583 High Similarity NPC477071
0.8583 High Similarity NPC319570
0.8571 High Similarity NPC473968
0.8571 High Similarity NPC474483
0.856 High Similarity NPC86159
0.856 High Similarity NPC469751
0.856 High Similarity NPC469755
0.856 High Similarity NPC469753
0.856 High Similarity NPC197707
0.856 High Similarity NPC329986
0.856 High Similarity NPC10823
0.856 High Similarity NPC471361
0.856 High Similarity NPC251866
0.856 High Similarity NPC140092
0.856 High Similarity NPC180079
0.856 High Similarity NPC70542
0.856 High Similarity NPC471359
0.856 High Similarity NPC89514
0.856 High Similarity NPC232785
0.856 High Similarity NPC284406
0.856 High Similarity NPC471407
0.856 High Similarity NPC9499
0.856 High Similarity NPC125077
0.856 High Similarity NPC471352
0.856 High Similarity NPC17896
0.856 High Similarity NPC469754
0.856 High Similarity NPC471360
0.856 High Similarity NPC276838
0.856 High Similarity NPC6108
0.856 High Similarity NPC188234
0.856 High Similarity NPC219085
0.856 High Similarity NPC471358
0.856 High Similarity NPC469752
0.8559 High Similarity NPC165439
0.8559 High Similarity NPC472274
0.8559 High Similarity NPC74727
0.8559 High Similarity NPC181145
0.8548 High Similarity NPC298841
0.8547 High Similarity NPC210420
0.8547 High Similarity NPC474265
0.8537 High Similarity NPC470922
0.8537 High Similarity NPC3381
0.8537 High Similarity NPC248202
0.8534 High Similarity NPC154856
0.8534 High Similarity NPC475317
0.8534 High Similarity NPC52241
0.8534 High Similarity NPC83005
0.8525 High Similarity NPC470265
0.8525 High Similarity NPC23786
0.8525 High Similarity NPC156789
0.8516 High Similarity NPC158350
0.8516 High Similarity NPC194716
0.8512 High Similarity NPC281840
0.8512 High Similarity NPC48692
0.8509 High Similarity NPC210178
0.85 High Similarity NPC475632
0.85 High Similarity NPC45475
0.85 High Similarity NPC86020
0.8492 Intermediate Similarity NPC476074
0.8492 Intermediate Similarity NPC262796
0.8492 Intermediate Similarity NPC213634
0.8492 Intermediate Similarity NPC329993
0.8492 Intermediate Similarity NPC475377
0.8492 Intermediate Similarity NPC264566
0.8492 Intermediate Similarity NPC172374
0.8492 Intermediate Similarity NPC134914
0.8492 Intermediate Similarity NPC45346
0.8492 Intermediate Similarity NPC478064
0.8492 Intermediate Similarity NPC173435
0.8492 Intermediate Similarity NPC475167
0.8492 Intermediate Similarity NPC301639
0.8492 Intermediate Similarity NPC477197
0.8492 Intermediate Similarity NPC478065
0.848 Intermediate Similarity NPC477078
0.848 Intermediate Similarity NPC475281
0.848 Intermediate Similarity NPC477075
0.848 Intermediate Similarity NPC329923
0.8475 Intermediate Similarity NPC62696
0.8475 Intermediate Similarity NPC75167
0.8475 Intermediate Similarity NPC293038
0.8475 Intermediate Similarity NPC311592
0.8475 Intermediate Similarity NPC260665
0.8475 Intermediate Similarity NPC251309
0.8468 Intermediate Similarity NPC473635
0.8468 Intermediate Similarity NPC250556
0.8468 Intermediate Similarity NPC469750
0.8468 Intermediate Similarity NPC293112
0.8462 Intermediate Similarity NPC79250
0.8462 Intermediate Similarity NPC285410
0.8462 Intermediate Similarity NPC290746
0.8462 Intermediate Similarity NPC263827
0.8462 Intermediate Similarity NPC250481
0.8462 Intermediate Similarity NPC75616
0.8455 Intermediate Similarity NPC160084
0.845 Intermediate Similarity NPC251998
0.845 Intermediate Similarity NPC329675
0.845 Intermediate Similarity NPC289700
0.845 Intermediate Similarity NPC59288
0.845 Intermediate Similarity NPC62172
0.8443 Intermediate Similarity NPC46570
0.8443 Intermediate Similarity NPC67569
0.843 Intermediate Similarity NPC475775
0.843 Intermediate Similarity NPC476529
0.843 Intermediate Similarity NPC197003
0.843 Intermediate Similarity NPC161738
0.843 Intermediate Similarity NPC475834
0.843 Intermediate Similarity NPC475041
0.843 Intermediate Similarity NPC474179
0.843 Intermediate Similarity NPC190939
0.8425 Intermediate Similarity NPC478153
0.8425 Intermediate Similarity NPC478152
0.8425 Intermediate Similarity NPC155529
0.8425 Intermediate Similarity NPC478150
0.8417 Intermediate Similarity NPC477252
0.8417 Intermediate Similarity NPC309433
0.8413 Intermediate Similarity NPC477079
0.8413 Intermediate Similarity NPC477076
0.8413 Intermediate Similarity NPC470912
0.8413 Intermediate Similarity NPC470913
0.8413 Intermediate Similarity NPC477196
0.8413 Intermediate Similarity NPC477077
0.8403 Intermediate Similarity NPC474557
0.8403 Intermediate Similarity NPC116024
0.8403 Intermediate Similarity NPC102088
0.8403 Intermediate Similarity NPC475163
0.8403 Intermediate Similarity NPC220293
0.84 Intermediate Similarity NPC179412
0.84 Intermediate Similarity NPC470516
0.84 Intermediate Similarity NPC471356
0.84 Intermediate Similarity NPC470780
0.839 Intermediate Similarity NPC233003
0.839 Intermediate Similarity NPC471967
0.839 Intermediate Similarity NPC477253
0.839 Intermediate Similarity NPC130427
0.839 Intermediate Similarity NPC174836
0.8387 Intermediate Similarity NPC32868
0.8387 Intermediate Similarity NPC130229
0.8387 Intermediate Similarity NPC469842
0.8387 Intermediate Similarity NPC241456
0.8387 Intermediate Similarity NPC7850
0.8387 Intermediate Similarity NPC473474
0.8387 Intermediate Similarity NPC8369
0.8387 Intermediate Similarity NPC469841
0.8387 Intermediate Similarity NPC6615
0.8385 Intermediate Similarity NPC596
0.8385 Intermediate Similarity NPC140045
0.8385 Intermediate Similarity NPC295885
0.8376 Intermediate Similarity NPC476766
0.8376 Intermediate Similarity NPC129340
0.8374 Intermediate Similarity NPC107493

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC318135 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.856 High Similarity NPD7319 Approved
0.8468 Intermediate Similarity NPD7507 Approved
0.8362 Intermediate Similarity NPD6686 Approved
0.8306 Intermediate Similarity NPD8328 Phase 3
0.8276 Intermediate Similarity NPD6412 Phase 2
0.8145 Intermediate Similarity NPD8513 Phase 3
0.8145 Intermediate Similarity NPD8033 Approved
0.8115 Intermediate Similarity NPD7115 Discovery
0.8065 Intermediate Similarity NPD8294 Approved
0.8065 Intermediate Similarity NPD8377 Approved
0.8047 Intermediate Similarity NPD7736 Approved
0.8017 Intermediate Similarity NPD8133 Approved
0.8 Intermediate Similarity NPD8515 Approved
0.8 Intermediate Similarity NPD8296 Approved
0.8 Intermediate Similarity NPD7503 Approved
0.8 Intermediate Similarity NPD8378 Approved
0.8 Intermediate Similarity NPD8335 Approved
0.8 Intermediate Similarity NPD8380 Approved
0.8 Intermediate Similarity NPD8379 Approved
0.8 Intermediate Similarity NPD8516 Approved
0.8 Intermediate Similarity NPD8517 Approved
0.7969 Intermediate Similarity NPD8293 Discontinued
0.7967 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7903 Intermediate Similarity NPD7328 Approved
0.7903 Intermediate Similarity NPD7327 Approved
0.784 Intermediate Similarity NPD7516 Approved
0.7833 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7795 Intermediate Similarity NPD6370 Approved
0.7674 Intermediate Similarity NPD7492 Approved
0.7638 Intermediate Similarity NPD6059 Approved
0.7638 Intermediate Similarity NPD6054 Approved
0.7638 Intermediate Similarity NPD6319 Approved
0.7615 Intermediate Similarity NPD6616 Approved
0.7557 Intermediate Similarity NPD7078 Approved
0.75 Intermediate Similarity NPD8297 Approved
0.75 Intermediate Similarity NPD6882 Approved
0.7458 Intermediate Similarity NPD7639 Approved
0.7458 Intermediate Similarity NPD7640 Approved
0.7442 Intermediate Similarity NPD6016 Approved
0.7442 Intermediate Similarity NPD6015 Approved
0.7419 Intermediate Similarity NPD8413 Clinical (unspecified phase)
0.7402 Intermediate Similarity NPD6009 Approved
0.7385 Intermediate Similarity NPD5988 Approved
0.7373 Intermediate Similarity NPD7638 Approved
0.736 Intermediate Similarity NPD6053 Discontinued
0.7302 Intermediate Similarity NPD4632 Approved
0.7295 Intermediate Similarity NPD5739 Approved
0.7295 Intermediate Similarity NPD6675 Approved
0.7295 Intermediate Similarity NPD6402 Approved
0.7295 Intermediate Similarity NPD7128 Approved
0.7258 Intermediate Similarity NPD6372 Approved
0.7258 Intermediate Similarity NPD6373 Approved
0.7241 Intermediate Similarity NPD6399 Phase 3
0.7227 Intermediate Similarity NPD4225 Approved
0.7213 Intermediate Similarity NPD8170 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD7320 Approved
0.7177 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD6881 Approved
0.7177 Intermediate Similarity NPD6899 Approved
0.7164 Intermediate Similarity NPD8074 Phase 3
0.7143 Intermediate Similarity NPD6649 Approved
0.7143 Intermediate Similarity NPD8130 Phase 1
0.7143 Intermediate Similarity NPD6650 Approved
0.712 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD6033 Approved
0.7097 Intermediate Similarity NPD5697 Approved
0.7097 Intermediate Similarity NPD5701 Approved
0.7069 Intermediate Similarity NPD46 Approved
0.7069 Intermediate Similarity NPD6698 Approved
0.7063 Intermediate Similarity NPD6371 Approved
0.7063 Intermediate Similarity NPD4634 Approved
0.7063 Intermediate Similarity NPD7102 Approved
0.7063 Intermediate Similarity NPD7290 Approved
0.7063 Intermediate Similarity NPD6883 Approved
0.7034 Intermediate Similarity NPD7748 Approved
0.7016 Intermediate Similarity NPD6008 Approved
0.7009 Intermediate Similarity NPD7983 Approved
0.7008 Intermediate Similarity NPD6869 Approved
0.7008 Intermediate Similarity NPD6847 Approved
0.7008 Intermediate Similarity NPD6617 Approved
0.7 Intermediate Similarity NPD6083 Phase 2
0.7 Intermediate Similarity NPD7902 Approved
0.7 Intermediate Similarity NPD6084 Phase 2
0.6984 Remote Similarity NPD6013 Approved
0.6984 Remote Similarity NPD6012 Approved
0.6984 Remote Similarity NPD6014 Approved
0.6983 Remote Similarity NPD5328 Approved
0.694 Remote Similarity NPD7604 Phase 2
0.694 Remote Similarity NPD6067 Discontinued
0.6929 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6917 Remote Similarity NPD5983 Phase 2
0.6911 Remote Similarity NPD7632 Discontinued
0.6911 Remote Similarity NPD5211 Phase 2
0.6905 Remote Similarity NPD6011 Approved
0.6875 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6864 Remote Similarity NPD7515 Phase 2
0.6864 Remote Similarity NPD6079 Approved
0.6864 Remote Similarity NPD7637 Suspended
0.6861 Remote Similarity NPD8336 Approved
0.6861 Remote Similarity NPD8337 Approved
0.686 Remote Similarity NPD4755 Approved
0.6842 Remote Similarity NPD4786 Approved
0.6838 Remote Similarity NPD6336 Discontinued
0.6835 Remote Similarity NPD7260 Phase 2
0.6825 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6815 Remote Similarity NPD7830 Approved
0.6815 Remote Similarity NPD7829 Approved
0.6807 Remote Similarity NPD5778 Approved
0.6807 Remote Similarity NPD5779 Approved
0.6803 Remote Similarity NPD8029 Clinical (unspecified phase)
0.68 Remote Similarity NPD5141 Approved
0.6752 Remote Similarity NPD6672 Approved
0.6752 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6752 Remote Similarity NPD5737 Approved
0.675 Remote Similarity NPD7900 Approved
0.675 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6748 Remote Similarity NPD5285 Approved
0.6748 Remote Similarity NPD5286 Approved
0.6748 Remote Similarity NPD4700 Approved
0.6748 Remote Similarity NPD4696 Approved
0.6728 Remote Similarity NPD7799 Discontinued
0.6724 Remote Similarity NPD6684 Approved
0.6724 Remote Similarity NPD7334 Approved
0.6724 Remote Similarity NPD6409 Approved
0.6724 Remote Similarity NPD7521 Approved
0.6724 Remote Similarity NPD5330 Approved
0.6724 Remote Similarity NPD7146 Approved
0.6723 Remote Similarity NPD6411 Approved
0.6696 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6694 Remote Similarity NPD5695 Phase 3
0.6693 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3667 Approved
0.6667 Remote Similarity NPD6274 Approved
0.6667 Remote Similarity NPD8444 Approved
0.6667 Remote Similarity NPD5696 Approved
0.6667 Remote Similarity NPD6921 Approved
0.6643 Remote Similarity NPD6914 Discontinued
0.6643 Remote Similarity NPD5956 Approved
0.6642 Remote Similarity NPD7101 Approved
0.6642 Remote Similarity NPD7100 Approved
0.664 Remote Similarity NPD4633 Approved
0.664 Remote Similarity NPD5226 Approved
0.664 Remote Similarity NPD5225 Approved
0.664 Remote Similarity NPD5224 Approved
0.6639 Remote Similarity NPD5221 Approved
0.6639 Remote Similarity NPD5785 Approved
0.6639 Remote Similarity NPD5222 Approved
0.6639 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6639 Remote Similarity NPD4697 Phase 3
0.6639 Remote Similarity NPD7839 Suspended
0.6614 Remote Similarity NPD4767 Approved
0.6614 Remote Similarity NPD4768 Approved
0.661 Remote Similarity NPD6903 Approved
0.6594 Remote Similarity NPD8451 Approved
0.6587 Remote Similarity NPD5174 Approved
0.6587 Remote Similarity NPD5175 Approved
0.6585 Remote Similarity NPD5173 Approved
0.6583 Remote Similarity NPD8035 Phase 2
0.6583 Remote Similarity NPD8034 Phase 2
0.6583 Remote Similarity NPD5693 Phase 1
0.6581 Remote Similarity NPD3618 Phase 1
0.6569 Remote Similarity NPD7642 Approved
0.6567 Remote Similarity NPD6335 Approved
0.656 Remote Similarity NPD5223 Approved
0.6557 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6555 Remote Similarity NPD4753 Phase 2
0.6555 Remote Similarity NPD6101 Approved
0.6555 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6552 Remote Similarity NPD3665 Phase 1
0.6552 Remote Similarity NPD3666 Approved
0.6552 Remote Similarity NPD3133 Approved
0.6549 Remote Similarity NPD6845 Suspended
0.6549 Remote Similarity NPD8338 Approved
0.6547 Remote Similarity NPD8448 Approved
0.6544 Remote Similarity NPD6908 Approved
0.6544 Remote Similarity NPD6909 Approved
0.6541 Remote Similarity NPD6868 Approved
0.6533 Remote Similarity NPD7625 Phase 1
0.6529 Remote Similarity NPD4202 Approved
0.6525 Remote Similarity NPD8390 Approved
0.6525 Remote Similarity NPD8392 Approved
0.6525 Remote Similarity NPD8391 Approved
0.6522 Remote Similarity NPD8299 Approved
0.6522 Remote Similarity NPD8341 Approved
0.6522 Remote Similarity NPD8342 Approved
0.6522 Remote Similarity NPD8340 Approved
0.6512 Remote Similarity NPD4729 Approved
0.6512 Remote Similarity NPD4730 Approved
0.65 Remote Similarity NPD7838 Discovery
0.6496 Remote Similarity NPD8080 Discontinued
0.6493 Remote Similarity NPD6317 Approved
0.6483 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6457 Remote Similarity NPD4754 Approved
0.6444 Remote Similarity NPD6314 Approved
0.6444 Remote Similarity NPD6313 Approved
0.6434 Remote Similarity NPD8449 Approved
0.6429 Remote Similarity NPD5344 Discontinued
0.6417 Remote Similarity NPD6904 Approved
0.6417 Remote Similarity NPD6080 Approved
0.6417 Remote Similarity NPD6673 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data